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A 36-year-old man was transferred to the hospital for further evaluation of pulmonary
infiltration. A diagnosis of acute eosinophilic pneumonia (AEP) was confirmed by clinical
symptoms, bronchoalveolar lavage, and computed tomography findings. Skin tests with
fungal antigens were performed by intradermal injection. Both the Arthus (8 h) and delay
(24 h)-type skin tests were positive for only Candida albicans. A lymphocyte-stimulating
test was also positive for C. albicans. The etiology of the AEP was confirmed by a C.
albicans inhalation provocation test. In addition, peripheral blood mononuclear cells
obtained from the patient produced Interleukin-5 following C. albicans stimulation. This is
the first report of C. albicans as a probable cause of AEP. Evaluation of allergy to C.
albicans should be performed in AEP before diagnosing the cause as idiopathic.
& 2007 Elsevier Ltd. All rights reserved.Introduction
Acute eosinophilic pneumonia (AEP) was first described in
1989.1,2 Since then, many factors such as drugs, cigarette
smoke, and fungi have been implicated as causes of AEP.3,4
There are few references in the literature regarding the role
of Candida albicans in eosinophilic lung disease,5 although itElsevier Ltd. All rights reserved.
586 5814;
-u.ac.jp (O. Matsuno).is well known that C. albicans is one of the aeroantigens that
causes bronchial asthma and allergic bronchopulmonary
candidiasis.6 We present here the first case of acute onset
eosinophilic pneumonia induced by C. albicans.Case report
A 36-year-old man with cough, general fatigue, slight fever,
and dyspnea was admitted to a local hospital. One week
before admission, he complained of a cough. Thereafter,
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Figure 2 C. albicans allergens induced IL-5 production in an
AEP patient. PBMCs obtained from our patient were cultured
with various concentrations of fungal allergens for 3 days. IL-5
concentrations of the resulting supernatants were assayed by
specific ELISA. LST: lymphocyte-stimulating test, Can: C.
albicans, Asp: A. fumigutus, Alt: Alternaria altrenata.
O. Matsuno et al.1610general fatigue and dyspnea appeared. A chest radiograph
on admission showed shadows disseminated over both the
mid and lower lung zones. Chest computed tomography (CT)
demonstrated diffuse ground glass opacities, reticular
shadows, and alveolar septal thickening (Fig. 1). Bronch-
oalveolar lavage (BAL) was performed. The BAL count was
7.98 105/ml, with 65.5% eosinophils, 5.9% lymphocytes, 2%
neutrophils, and 26.3% alveolar macrophages. The CD4:CD8
ratio in the bronchoalveolar lavage fluid (BALF) was 2.84. No
pathogen was identified. The patient was diagnosed with
AEP according to modified Allen’s criteria.1,7 His symptoms
spontaneously improved without specific therapy.
One week after admission, he was transferred to our
hospital for further evaluation of the disease. His past
medical history revealed neither asthma nor any occupa-
tional exposure to toxic fumes, dust, or animals. He was a
current smoker. Physical examination revealed a tempera-
ture of 36.8 1C and blood pressure of 119/49mmHg. Lung
auscultation revealed no abnormal sounds. There was no
heart murmur. Arterial blood gases were as follows: pH
7.392, HCO3 27.6mmol/l, pCO2 46.5mmHg, pO2 97.5mmHg,
and base excess 2.1mmol/l. The white blood cell count
(WBC) was 4.67 103/mm3 with 6.7% eosinophils and 60.6%
neutrophils. His hemoglobin concentration was 14.1 g/dl. C-
reactive protein was 0.11mg/dl. The total serum IgG, IgM,
and IgA levels were 972 g/dl, 27mg/dl (reference range [R]:
35–220), and 320mg/dl, respectively, and total serum IgE
was 348 IU/ml ([R]: o170). Specific IgE to 21 common
aeroallergens, including fungi antigens, was negative. His
chest radiograph was normal. A chest CT revealed that the
alveolar septal thickening and the ground glass opacities had
disappeared.
BAL was performed. Sterile saline (150ml) was instilled
into the right B8 segment in 50-ml aliquots. No pathogen was
identified. The BAL count was 3.76 105/ml, with 13.4%
eosinophils, 5.9% lymphocytes, 2% neutrophils, and 26.6%
alveolar macrophages. The CD4:CD8 ratio in the BALF was
2.4. No organisms grew in the BAL culture.
Skin testing by intradermal injection revealed that both
the Arthus (8 h) and delay (24 h)—type skin tests were
positive for only C. albicans allergens (Torii Pharmaceutical;
Tokyo, Japan), although the immediate reaction wasFigure 1 Chest CT demonstrated diffuse ground glass opa-
cities, reticular shadows, and alveolar septal thickening.negative. A lymphocyte-stimulating test (LST) for C.
albicans, Aspergillus fumigatus (A. fumigatus), and Alter-
naria alternata, expressed as stimulatory index (SI) (over
180% is considered positive), yielded values of 290%, 199%,
and 153%, respectively. We thought these clinical examina-
tions were more consistent with allergy to C. albicans. A
provocation test with C. albicans allergens (10,000-fold
dilution) was performed with careful observation under
informed consent. The patient developed a nonproductive
cough 1 h after the provocation. Eighteen hours later, his
body temperature had increased from 36.5 to 37.9 1C. The
WBC count and C-reactive protein before the provocation
were 5.70 103/mm3 and 0.02mg/dl, respectively, and rose
to 23.0 103/mm3 and 1.93mg/dl after the provocation,
respectively. PaO2 deceased to 93.3 from 98.4mmHg. Other
than a cough and mild decease of PaO2, radiologic changes
did not appear after the provocation test.
To clarify the causal allergens for eosinophilic inflamma-
tion and exclude possibility of cross sensitization, peripheral
blood mononuclear cells (PBMCs) obtained from the patient
were stimulated with various fungal allergens and Inter-
leukin-5 (IL-5) production was examined by enzyme-limked
immunosorbent assay (Instant ELISA, Vender, Vienna). IL-5
production was only detectable in PBMCs stimulated with C.
albicans allergens on day 3, although the proliferation
response to C. albicans and A. fumigatus allergens (LST) was
positive (Fig. 2). We therefore concluded that AEP was
induced by C. albicans.Discussion
AEP is characterized by a rapid onset of clinical symptoms
and signs associated with the presence of diffuse pulmonary
infiltrates on the chest radiograph and a high number of
eosinophils in the alveoli.1 AEP is most commonly idiopathic.
Other conditions associated with eosinophils, however, can
result in an AEP like clinical presentation. Thus, AEP can be
viewed as a syndrome that is idiopathic or a result of several
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Acute eosinophilic pneumonia caused by Candida albicans 1611causative conditions. Drug are sometimes associated with an
AEP syndrome.2 In addition, cigarette smoking was recently
recognized to cause AEP (CS-induced AEP) in Japan,
especially in a new-onset smoker.8 Our patient, however,
did not have drug-induced AEP and had a long smoking
history.
Fungal hypersensitivity, especially to Trichosporon ter-
restre and Aspergillus, causes eosinophilic pneumonia.9–11
Recently, Alternaria altenata, Schizophyllum commune, and
C. albicans were reported to cause of chronic eosinophilic
pneumonia.12,13,5 To our knowledge, this case is the first
reported case of AEP induced by C. albicans. A presumptive
diagnosis of C. albicans-induced pneumonia was made on
the basis of skin tests and LST results. The provocation test
with C. albicans led to the diagnosis. A provocation test with
specific antigens is useful for diagnosing pigeon breeder’s
disease,14 hypersensitivity pneumonitis,15 chronic eosino-
philic pneumonia,12 and smoking-induced AEP.4,8 It might
also be useful in determining the etiologic agents of
eosinophilic pneumonia.
Shintani et al.8 reported a case of CS-induced AEP
showing tolerance. Other than cough and mild decrease of
PaO2, pulmonary symptoms of radiological change and blood
eosinophilia did not appear after the provocation test in our
case. Watanabe et al.16 reported increase of eosinophils in
both BALF and TBLB developed without significant radi-
ological findings after challenge test. Neutrophilia in the
lung or blood is usually found during the early phase of
AEP.17 Nakajima et al.4 also reported that blood eosinophilia
was not observed after cigarette-smoking challenge test.
An association between environmental fungal exposure
and allergic pulmonary disease, such as asthma and
interstitial pneumonia, has been recognized clinically. This
association depends on immunologic reaction to endogenous
allergen.18,19 Mori et al.20 reported that C. albicans was
involved in eosinophil inflammation through the induction of
IL-5 production by Th cell.
The relevance of this allergen was further supported by
the induction of IL-5 production by patient’s PBMCs. IL-5 has
selective functions of eosinophil activation and recruitment
and is produced by CD4-positive Tcells. AEP is characterized
by locally high levels of IL-5 in the alveolar space. There is
evidence of increased production of IL-5 in the BALF of
patients with AEP.21 Taniguchi et al.22 also reported that
activated CD4 cells and IL-5 elevation contribute to the
development of AEP. PBMCs obtained from our patients
produced IL-5 upon stimulation with the C. albicans antigen,
but not A. fumigatus or Alternaria altrenata, although the
LST was also positive for A. fumigatus. These results
indicated that C. albicans allergens have contributed to
the airway eosinophilic inflammation through the induction
of IL-5 production by T cells in the present case. Cellular
immunity might therefore have an important role in
pulmonary eosinophilia.
In conclusion, we report here the first known case of C.
albicans induced-AEP. The clinical course, exclusion of
alternative causes, skin test, detection of IL-5 production
from PBMCs, and reaction to the provocation test were
useful for determining the etiology of the AEP.
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